Cosmetic Supply Chain Transparency Act of 2021
Latest action · Oct 11, 2021 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedOct 8, 2021
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Cosmetic Supply Chain Transparency Act of 2021
This bill requires the Food and Drug Administration (FDA) to maintain a list of certain nonfunctional constituents in cosmetics that are harmful to human health or the environment, authorizes the FDA to request from a brand owner (i.e., the entity bringing a cosmetic to market) certain information about a cosmetic's ingredients, and addresses related issues.
For each listed nonfunctional constituent, the list must identify the ingredient or cosmetic (or category of ingredient or cosmetic) in which the constituent is known or reasonably expected to be present. The FDA must also (1) establish procedures for petitions to add substances to the list, (2) issue guidance for industry related to testing and detecting such nonfunctional constituents, and (3) establish a committee to provide advice on creating the list and developing the required industry guidance.
Within a year of a nonfunctional constituent being added to the list, a supplier of an ingredient or cosmetic must test for that constituent and provide a brand owner the results and other information before selling the ingredient or cosmetic to the brand owner. A supplier of an ingredient or cosmetic must provide additional information about the item upon a brand owner's request.
Brand owners must maintain records with information about the suppliers of ingredients and raw materials used in their cosmetics and provide such information to the FDA upon request.
The bill also imposes civil penalties for brand owners and suppliers that violate this bill's provisions.
Cosponsors 9
Members who signed on, in the order they did. Signatures ran from Oct 22, 2021 to Sep 30, 2022.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-DC | Eleanor Holmes Norton | Oct 22, 2021 | |
| D-NY | Sean Patrick Maloney | Nov 3, 2021 | |
| D-MI | Daniel T. Kildee | Nov 9, 2021 | |
| D-MA | Lori Trahan | Nov 9, 2021 | |
| D-AZ | Raúl M. Grijalva | Dec 2, 2021 | |
| D-NY | Grace Meng | Mar 15, 2022 | |
| D-IL | Jesús G. "Chuy" García | Apr 26, 2022 | |
| D-WA | Pramila Jayapal | May 10, 2022 | |
| D-OH | Shontel M. Brown | Sep 30, 2022 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Oct 8, 2021 |
| Health Subcommittee | Referred Oct 11, 2021 |
Actions 3
Everything that happened, newest first.
- Oct 11, 2021Referred to the Subcommittee on Health.
- Oct 8, 2021Introduced in House
- Oct 8, 2021Referred to the House Committee on Energy and Commerce.
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 3622 | Cosmetic Supply Chain Transparency Act of 2023 | Reintroduced Bill | May 26, 2023 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend title VI of the Federal Food, Drug, and Cosmetic Act to ensure the supply chain transparency needed for companies to make safe cosmetics, and for other purposes.
- Short Title(s) as Introduced
- Cosmetic Supply Chain Transparency Act of 2021
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Administrative law and regulatory procedures
- Advisory bodies
- Business records
- Civil actions and liability
- Cosmetics and personal care
- Drug safety, medical device, and laboratory regulation
- Food and Drug Administration (FDA)
- Government information and archives
- Hazardous wastes and toxic substances
- Health
- Retail and wholesale trades
Text 1
Each version as it was printed, newest first.
- Oct 8, 2021Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.